Baseline Knowledge Uneven Among Cannabis Dispensary Personnel

THURSDAY, Aug. 18, 2022 (HealthDay News) -- Cannabis dispensary personnel are committed to their profession, but baseline cannabis knowledge is uneven and workplace training in cannabis therapeutics is unstandardized and weak, according to a study published online Aug. 15 in JCO Oncology Practice.
Ilana M. Braun, M.D., from Harvard Medical School in Boston, and colleagues conducted semistructured interviews across 13 states with cannabis dispensary personnel in managerial or client-facing positions. Twenty-six participants completed the interview.
The researchers found that the study participants endorsed passionate commitment to their profession and were frequently motivated by personal experience with medicinal cannabis therapeutics. When hiring, cannabis dispensaries often favored sales skills over cannabis therapeutics knowledge, resulting in inconsistent baseline levels of cannabis therapeutics expertise among staff. Workplace cannabis therapeutics training was reported to be unstandardized and weak by most participants. In terms of pursuing cannabis knowledge, dispensary personnel were described as resourceful, self-financing learning in off-hours, sampling dispensary products, and exchanging knowledge. Quality, standardized cannabis therapeutics training for dispensary personnel was called for by nearly half of the participants.
"Our study opens the door to discussing that we as clinicians may not be able to completely defer responsibility for advising patients to the dispensaries," Braun said in a statement. "We need to figure out ways to address this issue."
Several authors disclosed financial ties to the medical cannabis industry.
Related Posts
Increased Risk for Mortality Seen for Persons With Autism, ADHD
MONDAY, Feb. 14, 2022 (HealthDay News) -- The risk for mortality is increased...
Reproductive Factors Linked to Risk for Lung Cancer
FRIDAY, Sept. 15, 2023 (HealthDay News) -- Reproductive factors, including early...
AHA News: Worried About Her Health, She Lost 163 Pounds – And Inspired Her Husband to Drop 55
FRIDAY, Jan. 21, 2022 (American Heart Association News) -- A few weeks before...
In Rare Move, FDA Panel Gives Support to Controversial ALS Drug in Second Review
THURSDAY, Sept. 8, 2022 (HealthDay News) -- In a rare second review, a U.S. Food...
